Think about that for a moment
However, its detection is dependent on SSTR2 expression in the tumors, and small benign insulinomas are difficult to detect using SRS [1,2,3,4]
Unlike semaglutide, which targets only the GLP-1 receptor, tirzepatide is a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist simultaneously activating two key metabolic hormone pathways to produce an even more powerful effect on appetite suppression, fat metabolism, and blood sugar regulation
Limiting the analysis to those with a BMI of 35 or higher brought dropout rates down to 8.8% for the low dose and 12.1% for the high dose, compared with 4.8% for the placebo closer to the rates seen in Zepbound trials, but still higher
In clinical contexts, you need peptide vials lasting a minimum of 8 weeks, syringes, alcohol swabs, and bacteriostatic water